Cardiomyopathy, Dilated: Clinical Trials

242 trials for Cardiomyopathy, Dilated, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

97 completed, 57 unknown, 43 recruiting, 18 terminated. 59 Not applicable, 46 Phase 2, 26 Phase 1, 22 Phase 3, 9 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable59Completed 27, Unknown 12, Recruiting 5, Terminated 5, Active not recruiting 4, Withdrawn 3, Enrolling by invitation 1, Not yet recruiting 1, Suspended 1
Phase 246Completed 28, Recruiting 6, Unknown 6, Terminated 3, Active not recruiting 1, Suspended 1, Withdrawn 1
Phase 126Completed 8, Recruiting 8, Unknown 5, Terminated 3, Suspended 1, Withdrawn 1
Phase 322Completed 10, Terminated 5, Unknown 5, Recruiting 2
Phase 49Completed 7, Recruiting 1, Unknown 1
Early Phase 11Unknown 1

Follow Cardiomyopathy, Dilated: new trials by email Literature Review of Cardiomyopathy, Dilated trials Research Report on Cardiomyopathy, Dilated

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BAG3-DCM Natural History Study
Dilated Cardiomyopathy (DCM), Cardiovascular Diseases
Not yet recruitingRocket Pharmaceuticals Inc.302026-12-012026-10-19
An AAV Gene Therapy Trial of AFTX-201 in Adults With BAG3-Associated Dilated Cardiomyopathy (DCM)
AFTX-201 - Dilated Cardiomyopathy (DCM), BAG3 Mutation Associated Dilated Cardiomyopathy
Phase 1 / Phase 2RecruitingAffinia Therapeutics222026-10-012026-10-21
Observational Study of Natural History of BAG3 Gene Mutation-Associated Dilated Cardiomyopathy in Chinese Adults
Observational, None intervention - Dilated Cardiomyopathy
RecruitingAstraZeneca102026-08-182026-10-22
RHYthm and Myocardial Function Relationship Evaluation in Heart Diseases
speckle tracking echocardiography - Arrhythmia, Cardiomyopathy, Dilated
RecruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS2532026-06-232026-09-10
A Study With NVC-001 in Patients With LMNA-related Dilated Cardiomyopathy (SUNBEAM-LMNA)
NVC-001 - Low Dose, NVC-001 - Intermediate Dose, NVC-001 - High Dose - LMNA-Related Dilated Cardiomyopathy
Phase 1 / Phase 2RecruitingNuevocor Pte. Ltd.212026-06-162026-08-07
Safety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy
FAP immunosuppressive CAR-DC - Dilated Cardiomyopathy (DCM), Heart Failure
Phase 1RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine52026-05-112026-07-02
Effect of Sildenafil on Left Ventricular Function in Pediatric With Primary Dilated Cardiomyopathy
Cardiomyopathy, Dilated
Not yet recruitingAssiut University702026-05-102026-04-17
A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy
RP-A701 is a recombinant viral vector composed of an AAV serotype rh.74 (AAVrh.74) capsid encapsulating the transgene, BCL2-associated Athanogene 3 (BAG3) - Dilated Cardiomyopathy (DCM)
Phase 1RecruitingRocket Pharmaceuticals Inc.82026-04-172026-10-01
Mainstreaming Genetic Testing for Non-Ischemic Cardiomyopathy in Western Canada
Health service delivery change - Nonischemic Cardiomyopathy, Dilated Cardiomyopathy (DCM)
Not applicableEnrolling by invitationThomas Roston3002026-02-022026-05-08
Endocardial Delivery for Myocardial Regeneration Using Allogeneic iPSC-derived Cardiomyocyte Spheroids for HF With Systolic Dysfunction (EMERALD Study)
HS-005 - Heart Failure, Ischemic Heart Failure
Phase 1 / Phase 2RecruitingHeartseed Inc.142026-01-192026-10-22
Prognostic Values of Coronary Microvascular Dysfunction in Patients With Dilated Cardiomyopathy
coronary angiography - Dilated Cardiomyopathy (DCM)
RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine3302026-01-062025-12-19
A Study of AZD4063 in PLN R14del Dilated Cardiomyopathy
AZD4063 - Dilated Cardiomyopathy
Phase 1RecruitingAstraZeneca232025-12-012026-09-04
the Clinical Outcome of Empagliflozin in Pediatric Heart Failure Patients
Empagliflozin (EMPA), Standard medical treatment - Heart Failure
Phase 2RecruitingAin Shams University602025-12-012026-07-09
Study of the Progression of Chronic Cardiovascular Conditions
Cardiovascular Disease (CVD), Heart Failure
RecruitingProlaio50002025-10-302026-08-12
Multimodal Analysis of Endomyocardial Biopsies
Heart Transplantation, Dilated Cardiomyopathy (DCM)
RecruitingUniversity Hospital, Essen2162025-10-272026-01-22
MyocarditIRM-Génétique - Genetic Sub-study of the French Cohort of Acute Myocarditis Cases Diagnosed by MRI
Acute Myocarditis
Active not recruitingFrench Cardiology Society6022025-07-152026-07-21
A Phase 1 Open-Label Study of the Safety of Intravenous Allogeneic Neonatal Mesenchymal Cells (nMSCs) in Young Adult (1A) and Pediatric (1B) Patients With Dilated Cardiomyopathy (DCM)
Allogeneic Neonatal mesenchymal stromal cells (nMSCs) - Dilated Cardiomyopathy
Phase 1RecruitingEmory University362025-07-142026-06-26
Protein A Immunoadsorption in Dilated Cardiomyopathy (RPIA-DCM)
Immunoadsorption - Dilated Cardiomyopathy (DCM)
Not applicableRecruitingUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology602025-06-042025-06-04
National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Unified Health System Through a Multicenter Registry
whole genome sequencing - Cardiomyopathy, Hypertrophic, Cardiomyopathy, Dilated
RecruitingHospital do Coracao12112025-04-302026-05-08
Safety and Efficacy of FAP iCDC in End-stage Dilated Cardiomyopathy
FAP immunosuppressive CAR-DC - Dilated Cardiomyopathy (DCM), Heart Failure
Phase 1 / Phase 2RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine432025-04-222026-07-14

Showing 20 of 242. Sign in to see all of them.

Narrower conditions

Heart Failure (91)  ·  Cardiomyopathy, Hypertrophic (38)  ·  Cardiomyopathies (35)  ·  Cardiomyopathy, Restrictive (14)  ·  Arrhythmogenic Right Ventricular Dysplasia (13)  ·  Death, Sudden, Cardiac (13)  ·  Heart Diseases (12)  ·  Cardiovascular Diseases (11)  ·  Myocarditis (9)  ·  Arrhythmias, Cardiac (7)  ·  Coronary Disease (7)  ·  Myocardial Infarction (7)  ·  Myocardial Ischemia (6)  ·  Atrial Fibrillation (5)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (242)  ·  Cardiomegaly (241)  ·  Genetic Diseases, Inborn (241)  ·  Laminopathies (238)  ·  Cardiovascular Diseases (231)  ·  Heart Diseases (230)  ·  Cardiomyopathies (207)  ·  Pathological Conditions, Signs and Symptoms (49)  ·  Heart Valve Diseases (41)  ·  Pathologic Processes (40)  ·  Aortic Stenosis, Subvalvular (38)  ·  Aortic Valve Disease (38)  ·  Aortic Valve Stenosis (36)  ·  Vascular Diseases (30)  ·  Congenital Abnormalities (19)

Interventions

ARRY-371797 (3)  ·  Adrenergic beta-Antagonists (3)  ·  Cardiac Resynchronization Therapy (3)  ·  Carvedilol (3)  ·  Drug Therapy (3)  ·  Granulocyte Colony-Stimulating Factor (3)  ·  Standard of Care (3)  ·  Allopurinol (2)  ·  Blood Coagulation Tests (2)  ·  Blood Specimen Collection (2)  ·  Genetic Testing (2)  ·  Hematologic Tests (2)  ·  Ivabradine (2)  ·  Metoprolol (2)  ·  Plasmapheresis (2)

Sponsors

Imperial College London (9)  ·  University Medical Centre Ljubljana (6)  ·  LoneStar Heart, Inc. (4)  ·  Ancora Heart, Inc. (3)  ·  AstraZeneca (3)  ·  French Cardiology Society (3)  ·  Göteborg University (3)  ·  Hospital General Universitario Gregorio Marañon (3)  ·  Institut National de la Santé Et de la Recherche Médicale, France (3)  ·  Johns Hopkins University (3)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (3)  ·  Ministry of Health, Brazil (3)  ·  National Heart, Lung, and Blood Institute (NHLBI) (3)  ·  National Taiwan University Hospital (3)  ·  Pfizer (3)

Countries

United States (59)  ·  United Kingdom (26)  ·  China (22)  ·  France (21)  ·  Germany (21)  ·  Italy (17)  ·  Canada (16)  ·  Spain (16)  ·  Netherlands (13)  ·  Brazil (9)  ·  Poland (8)  ·  Denmark (7)  ·  Serbia (6)  ·  Slovenia (6)  ·  Sweden (6)

Top investigators

James Ware (3)  ·  Bojan Vrtovec, MD, PhD (2)  ·  Ida Jovanovic, Prof,MD,PhD (2)  ·  Javier Bermejo Thomas, MD, PhD (2)  ·  Michael Burch, Prof,MD,PhD (2)  ·  Michael R Bristow, MD PhD (2)  ·  Michael Zapien, MS, CCRA (2)  ·  Ray Hershberger, MD (2)  ·  Steven E Lipshultz, MD (2)  ·  Xinyang Hu, PhD (2)  ·  A. G. Kfoury, MD (1)  ·  Agata Bielecka-Dabrowa, PhD (1)

Results publications

PMID 36718638, PMID 38979608, PMID 17582361, PMID 22651868, PMID 22936827, PMID 23362308, PMID 24414062, PMID 25142002, PMID 26680013, PMID 28917683, PMID 37010012, PMID 42669063, PMID 10368877, PMID 11710893, PMID 12106931, PMID 12457625, PMID 14668703, PMID 14736546, PMID 15234411, PMID 16545646, PMID 17268122, PMID 17289576, PMID 17379833, PMID 17383291, PMID 17874006, PMID 18455424, PMID 18553028, PMID 19146917, PMID 19327618, PMID 19445426, PMID 19946241, PMID 20178563, PMID 20308616, PMID 21440864, PMID 21645332, PMID 21709064, PMID 22523306, PMID 22596155, PMID 22677278, PMID 22877814, PMID 22892122, PMID 23065358, PMID 23100283, PMID 23612920, PMID 23619365, PMID 24030420, PMID 24065463, PMID 24132734, PMID 24265000, PMID 24310562

NIH funding

2015 (2), 2019 (2), 2004 (1), 2009 (1), 2017 (1), 2018 (1), 2025 (1), K23HL071562 (1), R01HL028715 (1), R01HL036879 (1), R01HL048013 (1), R01HL071225 (1), R01HL080152 (1), R01HL110737 (1), R01HL111459 (1)